Ye J, Mills BN, Qin SS, Garrett-Larsen J, Murphy JD, Uccello TP, Han BJ, Vrooman TG, Johnston CJ, Lord EM, Belt BA, Linehan DC, Gerber SA. Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer. J Immunother Cancer. 2022 Jul;10(7):e004784. doi: 10.1136/jitc-2022-004784. PMID: 35851308.
Mills BN, Qiu H, Drage MG, Chen C, Mathew JS, Garrett-Larsen J, Ye J, Uccello TP, Murphy JD, Belt BA, Lord EM, Katz AW, Linehan DC, Gerber SA. Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy. Clin Cancer Res. 2022 Jan 1;28(1):150-162. doi: 10.1158/1078-0432.CCR-21-2495. Epub 2021 Dec 3. PubMed PMID: 34862242; PubMed Central PMCID: PMC8738140
Uccello TP, Kintzel SA, Mills BN, Murphy JD, Garrett-Larsen J, Battaglia NG, Rodriguez CJ, Drage MG, Ye J, Love TMT, Johnston CJ, Repasky EA, Qiu H, Linehan DC, Lord EM, Gerber SA. Development of an Orthotopic Murine Model of Rectal Cancer in Conjunction With Targeted Short-Course Radiation Therapy. Adv Radiat Oncol. 2022 Mar-Apr;7(2):100867. doi: 10.1016/j.adro.2021.100867. eCollection 2022 Mar-Apr. PubMed PMID: 35036637; PubMed Central PMCID: PMC8749199
Han BJ, Murphy JD, Qin S, Ye J, Uccello TP, Garrett-Larsen J, Belt BA, Prieto PA, Egilmez NK, Lord EM, Linehan DC, Mills BN, Gerber SA. Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinoma. Immunol Invest. 2020 Jun 4;:1-16. doi: 10.1080/08820139.2020.1765795. [Epub ahead of print] PubMed PMID: 32498585.
Ye J, Mills BN, Zhao T, Han BJ, Murphy JD, Patel AP, Johnston CJ, Lord EM, Belt BA, Linehan DC, Gerber SA. Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Treat Pancreatic Cancer. Cancer Immunol Res. 2020 Jan;8(1):94-107. doi: 10.1158/2326-6066.CIR-19-0373. Epub 2019 Nov 12. PubMed PMID: 31719057; PubMed Central PMCID: PMC6946873.
Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment.Mills BN, Connolly KA, Ye J, Murphy JD, Uccello TP, Han BJ, Zhao T, Drage MG, Murthy A, Qiu H, Patel A, Figueroa NM, Johnston CJ, Prieto PA, Egilmez NK, Belt BA, Lord EM, Linehan DC, Gerber SA. Cell reports; Vol 29(2). 2019 Oct 08.
Increasing the efficacy of radiotherapy by modulating the CCR2/CCR5 chemokine axes. Connolly KA, Belt BA, Figueroa NM, Murthy A, Patel A, Kim M, Lord EM, Linehan DC, Gerber SA. Oncotarget. 2016; 7(52):86522-86535. PMCID: PMC5349932
Total-Body Irradiation Exacerbates Dissemination of Cutaneous Candida Albicans Infection. Barlow ML, Cummings RJ, Pentland AP, Love TM, Haidaris CG, Ryan JL, Lord EM, Gerber SA. Radiation research. 2016; 186(5):436-446. PMCID:PMC5326582
Radiation therapy combined with Listeria monocytogenes-based cancer vaccine synergize to enhance tumor control in the B16 melanoma model. Lim JY, Brockstedt DG, Lord EM, Gerber SA. Oncoimmunology. 2014; 3:e29028. PMCID:PMC4106167
Radio-responsive tumors exhibit greater intratumoral immune activity than nonresponsive tumors. Gerber SA, Lim JY, Connolly KA, Sedlacek AL, Barlow ML, Murphy SP, Egilmez NK, Lord EM. International journal of cancer. 2014; 134(10):2383-92. PMCID: PMC3949198
IFN-γ mediates the antitumor effects of radiation therapy in a murine colon tumor. Gerber SA, Sedlacek AL, Cron KR, Murphy SP, Frelinger JG, Lord EM. The American journal of pathology. 2013; 182(6):2345-54. PMCID:PMC3668027
View All Publications